According to Dr. Jesse Papenberg, a pediatric infectious disease specialist and microbiologist at Montreal Children’s Hospital, vaccinating children between the ages of 5 and 11 marks the “beginning of the end of the health crisis” for COVID-19.
According to the doctor, vaccinating people of this age will “show a significant reduction in community transmission.”
Children 5-11 years of age need to see when the vaccine starts and how it works.
According to Dr. Papenberg, if Pfizer-Bioentech files for a vaccine license for children on Monday, it will be a few weeks before Health Canada makes a decision.
A plan must be added to this deadline, according to which the provinces must continue and supply the vaccine.
“We know this is a new product, so there is a question about the product and supply to vaccinate children,” explained Dr. Jesse Papenberg.
Children vaccinated with Kovid-19 receive a dose equivalent to one-third of the normal dose given to adults and adolescents.
“According to the Pfizer press release, this small dose can get as high antibody levels as adults and adolescents at full dose. And when we talk about small doses, we are also talking about risk and minor side effects,” the pediatrician said.
According to Dr. Jesse Papenberg, children also need two doses to get the immunity they want.
“With the Delta variant, I think we’re going to talk about two doses because we know we really need a second dose to build enough antibodies to reduce the risk of infection,” he said.
The interval between doses should be determined, but the pediatrician should expect an interval of at least eight weeks.
Dr. Papenberg believes that an eight-week break in Canada and Quebec seems appropriate and that long-term survival is less than the three to four weeks studied in early clinical studies.